Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/15/22
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/01/20
End: 10/31/20
Due: 10/31/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout | NCT05522504 | Ai Peng | user2@example.com | None | 2022-09-15 | 2025-02-28 | 2026-02-28 | - | - | 2025-07-14 |
| The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients | NCT04600219 | Ai Peng | user2@example.com | None | 2018-01-01 | 2021-12-01 | 2022-12-01 | - | - | 2025-07-14 |
| Role of CVVH in Patients With Acute Paraquat Poisoning | NCT01709604 | Ai Peng | user2@example.com | None | 2012-10-31 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| Clinical Evaluation Study of a Device for Detecting Arteriovenous Fistula Vascular Function | NCT05531825 | Ai Peng | user2@example.com | None | 2022-05-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Role of Uralyt-U in Patients With Hyperuricemia | NCT04352153 | Ai Peng | user2@example.com | None | 2020-04-01 | 2020-10-31 | 2021-10-31 | - | - | 2025-07-14 |